Articles

Analysts: Investors wrong to dump Endocyte

Investors on Friday dumped shares of West Lafayette-based Endocyte Inc. after an independent analysis said an experimental lung cancer drug is unlikely to be declared superior to existing chemotherapy. But two analysts say, to the contrary, the analysis shows the prospects for Endocyte’s drug are as good as ever.

Read More

Finding where the money is in health care

More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.

Read More

Lilly stock shrugs off analyst downgrade

The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.

Read More

Financial pressures stretching Lilly

In a series of presentations, Lilly executives stretched themselves in four directions at once to convince investors and stock analysts that the company will bend but not break next year, and then snap back stronger than ever in 2015.

Read More

Lilly to buy back $5B as sales goal harder to reach

Eli Lilly and Co. said Thursday that meeting its sale target will be a challenge. It plans to repurchase $5 billion in shares and introduce new diabetes drugs to help navigate through patent losses. Another immediate hurdle: Obamacare.

Read More

Pressure mounts to fix health insurance exchanges

The pressure is on for the federal government and states running their own health insurance exchanges to get the systems up and running after overloaded websites and jammed phone lines frustrated consumers for a second day.

Read More

THOMAS: Confusion about health care act abounds

As president of a professional employer organization, I spend an enormous amount of time dealing with the complexities of the Affordable Care Act from the perspective of an employer sponsoring a health insurance plan.

Read More

ROSSWURM: Parents are scrambling to cover autism

As a parent of a young adult with autism and as a leader of an applied behavior analysis (ABA) therapy center focused on autism, I know firsthand about the challenges in finding appropriate and affordable insurance coverage to support special needs children.

Read More